Cooperative AgreementPostedDiscretionary

Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (MRA-HBV)

National Institutes of Health
FOR-AI-27-017
Application Deadline
Days Remaining
Until deadline
Award Ceiling
Total Program Funding
$8,000,000

Grant Opportunity Analysis

The National Institutes of Health (NIH) is inviting applications for the Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (MRA-HBV) program, aimed at advancing research in the field of infectious diseases. This initiative seeks to support innovative research that elucidates mechanisms of persistence and pathogenesis of Hepatitis B, develops clinically relevant biomarkers, identifies new drug targets, and creates non-invasive diagnostics, leveraging existing clinical data and sample repositories. With an estimated total program funding of $8 million and the expectation of awarding two grants, interested small businesses should note that the application process is open, with key deadlines including an estimated synopsis close date of August 19, 2026, and an anticipated award date of March 1, 2027. For further inquiries, applicants can contact Josh Radke, Ph.D., at josh.radke@nih.gov or by phone at 301-761-6525.

Eligible Applicants

Small Businesses

Grant Documents

0 Files
No documents available for this grant.

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedJun 27, 2025

Funding Details

Est. Total Program Funding
$8,000,000
Expected Awards
2
No cost sharing required

Agency & Classification

Agency
National Institutes of Health(HHS-NIH11)
Funding Category
Health
Funding Instrument
Cooperative Agreement

Grantor Contact

Name
Josh Radke, Ph.D. National Institute of Allergy and Infectious Disease (NIAID)

CFDA Numbers

93.855

Official Sources